We are proud to announce that Logical Biological has been honoured with the King’s Award for Enterprise. This prestigious award recognises Logical Biological’s excellence in International Trade for Outstanding Short-Term Growth in overseas sales over the last three years (2020-2022), which amounted to a more than one hundred and seventy per cent increase in international revenues during the period. This growth was achieved organically, amidst the challenging circumstances of the COVID-19 pandemic and is a mark of the company’s excellent reputation and unwavering commitment to providing high-quality biological samples to its diagnostic and therapeutic customers.


The King’s Awards for Enterprise, previously known as The Queen’s Awards for Enterprise, were renamed last year to reflect His Majesty The King’s desire to continue the legacy of HM Queen Elizabeth II’s by recognising outstanding UK businesses. The Award programme, now in its 58th year, is the most prestigious business award in the country. The awards celebrate the success of exciting and innovative businesses which are leading the way in one of four categories: Innovation, International Trade, Sustainable Development and Promoting Opportunity (through social mobility).


“We are delighted to receive the King’s Award for International Trade, which affirms our role as a leader in the global biospecimens market,” expressed Dr James Steggles, Managing Director of Logical Biological. “This award is a testament to the tireless efforts of our team and the trust our customers place in us as their supplier of choice for high-quality biospecimens. Our commitment to excellence not only propels our growth but also significantly furthers our mission to contribute to a healthier world.”

Kings Award For Enterprise International Trade Emblem

Over the three-year period, Logical Biological worked with a record number of customers, including many of the top 10 global leading companies in In Vitro Diagnostics (IVD) test manufacturing. It shipped products to twenty-four countries (including the USA, Germany, South Korea, Ireland, and Australia), and continues to expand its reach globally. The success of Logical Biological on a global scale can be attributed to its comprehensive range of biological samples and its commitment to quality, reliability, customer service, and responsiveness. The company’s deep understanding of the international scientific community’s needs, coupled with its focus on a customer-centric approach and strict quality control protocols, ensure superior product quality and customer satisfaction.


Lowri Cope, Commercial Director at Logical Biological, added, “We are immensely proud to be recognized for our outstanding growth in international trade. Our strong relationships within the global In Vitro Diagnostics (IVD) community form the foundation of our success. We are excited to continue this trajectory, expanding our partnerships and enhancing our role in diagnostics and therapeutic research and development.”


This recognition is not just an award but a reflection of Logical Biological’s dedication to impacting the global healthcare landscape positively.

We’re excited to share a milestone in our journey at Logical Biological. Our relentless dedication to customer centricity and unwavering commitment to quality has led to us securing 149th spot in the prestigious “FT 1000: Europe’s Fastest Growing Companies” listing, a recognition that fills us with immense pride and joy.


The “FT 1000” list, created in collaboration with Statista, shines a spotlight on the European companies that have shown extraordinary growth. The ranking is determined by analysing the compound annual growth rate (CAGR) in revenue from 2019 to 2022. In a list that is dominated by IT, Software, Construction and Energy/ Utility companies, Logical Biological is proud to be leading the way for science.


Our Managing Director, Dr James Steggles, reflects on this achievement with gratitude, attributing it to the hard work of our team and the trust our customers place in us. “This recognition validates our team’s dedication and the close relationships we’ve built with our partners who share our vision of creating a healthier world. It’s their trust in us as a provider of high-quality biospecimens that has propelled our growth.”

FT 1000: Europe's Fastest Growing Companies

Our position in the list is not just a number—it’s a narrative of our dedication to delivering excellence. Our expansive array of biological samples, combined with our focus on responsiveness, reliability, and quality, illustrates our commitment to the scientific community. We strive to understand and meet their needs ensuring that our products and services exceed expectations and maintain the highest quality standards.


Lowri Cope, Commercial Director, echoes this sentiment, expressing enthusiasm for our future endeavours. “Being acknowledged as one of Europe’s fastest-growing companies is a milestone that fuels our ambition. We look forward to building on this success and forging new partnerships in the advancement of scientific research and healthcare.”


As we celebrate this achievement, we’re not just looking back at our successes—we’re looking forward to the opportunities that lie ahead. Our vision is clear. Join us as we continue to forge ahead, solidifying our role as your trusted partner for biospecimens.

Logical Biological were delighted to exhibit for the first time at MEDICA, in Dusseldorf, Germany from 14 – 17 November 2022.

MEDICA – Leading International Trade Fair

MEDICA 2022 Infographic

MEDICA is one of the largest international events for the IVD Diagnostic industry and Logical Biological was one of over 5,000 exhibitors from over 70 countries . Logical Biological was pleased to see that visitor numbers were up from 2021 to more than 81,000 visitors, a significant increase from the 46,000 visitors that attended in 2021. In fact, MEDICA felt almost back to its pre-Covid self with the share of international visitors totalling 75 percent. European countries topped the visitor numbers, followed by South Korea and the USA. India and North African countries were also represented in large numbers. Many visitors noted that after the long pandemic break, they were happy to be able to talk to exhibitors again.

Logical Biological at MEDICA 2022

For Logical Biological, this was the first time exhibiting at MEDICA. Exhibiting gave us the opportunity to increase awareness within the industry of who Logical Biological are and how we can support and empower IVD manufacturers to develop high performance assays and associated calibrator and control material.

Thanks to some bold back-lit graphics we were a noticeable presence in the UK Gambica area of Hall 1, which enabled us to have many conversations with passing visitors, who we look forward to building working relationships with. Our team of three enjoyed over 30 pre-arranged meetings with customers and suppliers, and many more spontaneous ones. Better still, thanks to the support of Gambica we were able to have 2 meetings simultaneously by utilising the shared meeting area that Gambica offers.

MEDICA is always good way to get an overview of the market, to network and to see what the other companies are doing and where the trends are, this year was no exception. We look forward to attending more trade shows this year and further building the relationships we started at MEDICA.


Logical Biological Products

Logical Biological specialises in provision of human biospecimens, such as serum, plasma, swabs and saliva, all of which are essential components used in IVD tests, their development, calibration and quality control. 

Date of the next MEDICA in Düsseldorf: 13 –16 November 2023